Eramet S.a.
ERMAY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $3 | $3 | $5 | $4 |
| % Growth | -12.2% | -33.4% | 35.1% | – |
| Cost of Goods Sold | $1 | $1 | $4 | $3 |
| Gross Profit | $2 | $2 | $1 | $1 |
| % Margin | 58.4% | 59.9% | 24.6% | 20.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $1 |
| SG&A Expenses | $0 | $0 | -$0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $2 | $2 | $0 | $0 |
| Operating Expenses | $2 | $2 | $0 | $0 |
| Operating Income | $0 | -$0 | $1 | $1 |
| % Margin | 1.7% | -5.8% | 20.4% | 23.7% |
| Other Income/Exp. Net | -$0 | $0 | $0 | $0 |
| Pre-Tax Income | $0 | $0 | $1 | $1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | $0 | $1 | $0 |
| % Margin | 0.5% | 3.3% | 14.8% | 8% |
| EPS | 0.05 | 0.34 | 2.58 | 1.04 |
| % Growth | -85.3% | -86.8% | 148.1% | – |
| EPS Diluted | 0.05 | 0.36 | 2.55 | 1.04 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | $1 | $1 |
| % Margin | 16% | 7.3% | 26.4% | 31% |